Purchase Order 75D30124P00063

On August 7, 2024, the Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $33,000 firm fixed-price purchase order to Bio-Rad Laboratories Inc. for FDA-approved test kits, readers, and laptops to strengthen rapid test quality assurance operations. The contract, which has an ultimate completion date of April 22, 2025, utilizes these diagnostic testing products for validation and ongoing quality assurance of sample testing in international contexts. The work will be performed at Bio-Rad's facility in Hercules, California. This is an unrestricted procurement with no small business set-aside designation, reflecting Bio-Rad's status as a large established federal contractor with extensive experience supplying specialized laboratory equipment and diagnostic solutions across multiple government agencies.

This purchase order supports CDC's critical quality assurance mission and represents a modest individual transaction within Bio-Rad's broader federal contracting portfolio. Bio-Rad Laboratories Inc. maintains significant indefinite delivery vehicles and blanket purchase agreements with federal agencies including the Department of Health and Human Services, National Institutes of Health, Department of Veterans Affairs, and Defense Health Agency, through which the company supplies advanced diagnostic instrumentation, PCR systems, immunoassay platforms, and related supplies. The award was issued under the President's DOGE cost efficiency initiative framework, as indicated by the implementing notice designation.